Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mikail, Dogan"'
Autor:
Mikail Dogan, Lina Kozhaya, Lindsey Placek, Courtney Gunter, Mesut Yigit, Rachel Hardy, Matthew Plassmeyer, Paige Coatney, Kimberleigh Lillard, Zaheer Bukhari, Michael Kleinberg, Chelsea Hayes, Moshe Arditi, Ellen Klapper, Noah Merin, Bruce Tsan-Tang Liang, Raavi Gupta, Oral Alpan, Derya Unutmaz
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Using SARS-CoV-2-specific antibody- and neutralization assays, Dogan et al find that hospitalized individuals show higher IgG antibody responses and higher neutralization titers compared to outpatient or convalescent plasma donors, providing insights
Externí odkaz:
https://doaj.org/article/0a236342fbca4be7ad7450120dc25e6b
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 10, Pp n/a-n/a (2022)
Abstract Objectives Despite advances in antibody treatments and vaccines, COVID‐19 caused by SARS‐CoV‐2 infection remains a major health problem resulting in excessive morbidity and mortality and the emergence of new variants has reduced the ef
Externí odkaz:
https://doaj.org/article/03b8922c2f4b4b9dbac889c8166f8a9f
Publikováno v:
The Journal of Immunology. 209:1523-1531
Engineering immune cells with chimeric Ag receptors (CARs) is a promising technology in cancer immunotherapy. Besides classical cytotoxic CD8+ T cells, innate cell types such as NK cells have also been used to generate CAR-T or CAR-NK cells. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f2b17a20a2c3737923be2400101225
https://doi.org/10.4049/jimmunol.2100856
https://doi.org/10.4049/jimmunol.2100856
Engineering immune cells with chimeric antigen receptors (CAR) is a promising technology in cancer immunotherapy. Besides classical cytotoxic CD8+ T cells, innate cell types such as NK cells have also been used to generate CAR-T or CAR-NK cells. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::663b91490e9a1ca25af6dda9531aed6f
https://doi.org/10.1101/2022.07.28.501764
https://doi.org/10.1101/2022.07.28.501764
Autor:
Madhuri Dey, Myong Hwan Kim, Momoka Nagamine, Mikail Dogan, Lina Kozhaya, Derya Unutmaz, Ibrahim T. Ozbolat
Despite substantial advancements in development of cancer treatments, lack of standardized and physiologically-relevant in vitro testing platforms limit the rapid and early screening of anti-cancer agents. A major barrier in this endeavor, is the com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::046fa27ac7a6d84c7730fa70215ad1c5
https://doi.org/10.1101/2022.03.15.484485
https://doi.org/10.1101/2022.03.15.484485
Autor:
Rabab Nasrallah, Dafni A. Glinos, Adrian Liston, Lindsey Placek, Howard Y. Chang, Enrico Lugli, Sarah K. Whiteside, Teresa Lozano, Toshitsugu Fujita, Lina Kozhaya, Francis M. Grant, Rahul Roychoudhuri, Mikail Dogan, Maxwell R. Mumbach, Jie Yang, Charlotte J. Imianowski, Suman Mitra, Gosia Trynka, Derya Unutmaz, Hodaka Fujii, Panagiota Vardaka, Paula Kuo, Lara Bossini-Castillo, Firas Sadiyah, Carly E. Whyte, Adeline Cozzani, Simon Andrews
Publikováno v:
Nature. 583:447-452
Genetic variations underlying susceptibility to complex autoimmune and allergic diseases are concentrated within noncoding regulatory elements termed enhancers1. The functions of a large majority of disease-associated enhancers are unknown, in part o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::985aaa5ed38002ce4d7c1c653f380fea
https://doi.org/10.1038/s41586-020-2296-7
https://doi.org/10.1038/s41586-020-2296-7
Autor:
Madhuri Dey, Myong Hwan Kim, Momoka Nagamine, Ece Karhan, Lina Kozhaya, Mikail Dogan, Derya Unutmaz, Ibrahim T. Ozbolat
Immunotherapy has revolutionized cancer treatment with the advent of advanced cell engineering techniques aimed at targeted therapy with reduced systemic toxicity. However, understanding the underlying immune-cancer interactions require development o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2293c14202e9e652e47d43dfe35e00a4
https://doi.org/10.1101/2022.01.29.478309
https://doi.org/10.1101/2022.01.29.478309
Autor:
Madhuri Dey, Myoung Hwan Kim, Mikail Dogan, Momoka Nagamine, Lina Kozhaya, Nazmiye Celik, Derya Unutmaz, Ibrahim T. Ozbolat
Publikováno v:
Advanced Functional Materials. 32:2270296
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dd6b941627637ed5438299ce664a910
https://doi.org/10.1002/adfm.202270296
https://doi.org/10.1002/adfm.202270296
Autor:
Madhuri Dey, Myong Hwan Kim, Momoka Nagamine, Ece Karhan, Lina Kozhaya, Mikail Dogan, Derya Unutmaz, Ibrahim T Ozbolat
Publikováno v:
Biofabrication. 14:044105
Immunotherapy has revolutionized cancer treatment with the advent of advanced cell engineering techniques aimed at targeted therapy with reduced systemic toxicity. However, understanding the underlying immune–cancer interactions require development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a281989ab5b2d57cc40b08c9365c5d9b
https://doi.org/10.1088/1758-5090/ac925a
https://doi.org/10.1088/1758-5090/ac925a
Autor:
Joelynn Dailey, Michael Brimacombe, Faith Karabacak, Mikail Dogan, John Schreiber, Lina Kozhaya, Dena Hopkins, Katherine W. Herbst, Jeffrey S. Hyams, Kristen Grandonico, Bruce T. Liang, Blaine Lapin, Juan C. Salazar, Derya Unutmaz
Publikováno v:
medRxiv
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
BackgroundCharacterization of neutralization antibodies to SARS-CoV-2 infection or vaccination in children and young adults with inflammatory bowel disease (IBD) receiving biologic therapies is crucial.MethodsWe performed a prospective longitudinal c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a45c128014f1901e62e128fbc161c3
https://doi.org/10.1101/2021.06.12.21258810
https://doi.org/10.1101/2021.06.12.21258810